The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task

The effects of serotonergic dysfunction induced by treatment with p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis, and cholinergic dysfunction induced by scopolamine on the performance of adult rats in the 5-choice serial reaction time task measuring selective attention were studie...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Behavioural brain research 1992-10, Vol.51 (1), p.29-40
Hauptverfasser: JÄKÄLÄ, P, SIRVIÖ, J, JOLKKONEN, J, RIEKKINEN, P. JR, ACSADY, L, RIEKKINEN, P
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 40
container_issue 1
container_start_page 29
container_title Behavioural brain research
container_volume 51
creator JÄKÄLÄ, P
SIRVIÖ, J
JOLKKONEN, J
RIEKKINEN, P. JR
ACSADY, L
RIEKKINEN, P
description The effects of serotonergic dysfunction induced by treatment with p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis, and cholinergic dysfunction induced by scopolamine on the performance of adult rats in the 5-choice serial reaction time task measuring selective attention were studied. Food-deprived rats were trained to detect and respond to brief flashes of light presented randomly in one of five locations, until they reached a stable level of performance (about 4 months). Scopolamine 0.2 mg/kg produced a marked variation in the performance but did not, however, induce any consistent impairment in the discriminative accuracy. Other doses of scopolamine (0.05 and 0.1 mg/kg) or N-methyl-scopolamine 0.2 mg/kg, a peripheral muscarinic receptor antagonist, did not affect discriminative accuracy. Furthermore, scopolamine as well as N-methyl-scopolamine produced a number of other performance deficits, such as significantly decreased overall probability of responding and significantly increased response latencies. PCPA treatment induced an almost total depletion (> 99%) of frontal cortical serotonin and its major metabolite 5-HIAA and reduced the frontal cortical concentrations of noradrenaline (-30%) and dopamine (-42%). During baseline testing conditions, there was a trend for the discriminative accuracy to be decreased by PCPA, although this effect failed to reach significance (P = 0.07). Presenting the stimuli at unpredictable intervals or reducing the intensity of the visual stimulus impaired discriminative accuracy in both PCPA-treated and control rats. The decrease in discriminative accuracy induced by PCPA reached statistical significance when the stimuli were presented faster than normally or the intensity of the visual stimulus was reduced. PCPA treatment did not make the rats more susceptible to the effects of scopolamine on discriminative accuracy. However, PCPA treatment also induced a number of other performance deficits, resulting in a decreased overall tendency to respond. In summary, there is a statistically non-significant trend for the discriminative accuracy to be decreased by PCPA treatment under normal testing conditions, and as the discrimination task is made more difficult (stimulus intensity reduction, presentation of the stimuli at faster than normal rates), the deficit in discriminative accuracy produced by PCPA treatment is revealed. The results suggest a role for brain serotonin in the general organization of behavior.
doi_str_mv 10.1016/S0166-4328(05)80309-2
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_73441748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73441748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c250t-4ce8439b9962e1f6b80d40bedcdfadca664122a82f393120f96899d885f006263</originalsourceid><addsrcrecordid>eNqFkc1q3DAUhUVoSSdpHiGgRSnNwo3-LEvLEvoHgS6argdZusJqbMmV5MW8UJ4zmnbItpsruOe758ARQteUfKSEytufbchOcKY-kP5GEU50x87QjqqBdUMv9Cu0e0HeoItSfhNCBOnpOTqnTDFFhx16epgAg_dga8HJ47Wz05xyWieIh9nMJoYIXYhus-BwgZxqaitcDrFOUELBIU5hDDWkiE10eNmKNTnEYPE4J_toHOAmNRivkH3Ki4kWjlHZ1OM1NrhvoSm0bfMPZsYZjP1rWMMCuJry-Ba99mYucHV6L9GvL58f7r519z--fr_7dN9Z1pPaCQtKcD1qLRlQL0dFnCAjOOu8cdZIKShjRjHPNaeMeC2V1k6p3hMimeSX6P0_3zWnPxuUul9CsTC3HiBtZT9wIegg1H9BKrlqWUfw-gRu4wJuv-awmHzYn36g6e9OumnFzT63ekJ5wY5xg9L8GcSlmME</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16384128</pqid></control><display><type>article</type><title>The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>JÄKÄLÄ, P ; SIRVIÖ, J ; JOLKKONEN, J ; RIEKKINEN, P. JR ; ACSADY, L ; RIEKKINEN, P</creator><creatorcontrib>JÄKÄLÄ, P ; SIRVIÖ, J ; JOLKKONEN, J ; RIEKKINEN, P. JR ; ACSADY, L ; RIEKKINEN, P</creatorcontrib><description>The effects of serotonergic dysfunction induced by treatment with p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis, and cholinergic dysfunction induced by scopolamine on the performance of adult rats in the 5-choice serial reaction time task measuring selective attention were studied. Food-deprived rats were trained to detect and respond to brief flashes of light presented randomly in one of five locations, until they reached a stable level of performance (about 4 months). Scopolamine 0.2 mg/kg produced a marked variation in the performance but did not, however, induce any consistent impairment in the discriminative accuracy. Other doses of scopolamine (0.05 and 0.1 mg/kg) or N-methyl-scopolamine 0.2 mg/kg, a peripheral muscarinic receptor antagonist, did not affect discriminative accuracy. Furthermore, scopolamine as well as N-methyl-scopolamine produced a number of other performance deficits, such as significantly decreased overall probability of responding and significantly increased response latencies. PCPA treatment induced an almost total depletion (&gt; 99%) of frontal cortical serotonin and its major metabolite 5-HIAA and reduced the frontal cortical concentrations of noradrenaline (-30%) and dopamine (-42%). During baseline testing conditions, there was a trend for the discriminative accuracy to be decreased by PCPA, although this effect failed to reach significance (P = 0.07). Presenting the stimuli at unpredictable intervals or reducing the intensity of the visual stimulus impaired discriminative accuracy in both PCPA-treated and control rats. The decrease in discriminative accuracy induced by PCPA reached statistical significance when the stimuli were presented faster than normally or the intensity of the visual stimulus was reduced. PCPA treatment did not make the rats more susceptible to the effects of scopolamine on discriminative accuracy. However, PCPA treatment also induced a number of other performance deficits, resulting in a decreased overall tendency to respond. In summary, there is a statistically non-significant trend for the discriminative accuracy to be decreased by PCPA treatment under normal testing conditions, and as the discrimination task is made more difficult (stimulus intensity reduction, presentation of the stimuli at faster than normal rates), the deficit in discriminative accuracy produced by PCPA treatment is revealed. The results suggest a role for brain serotonin in the general organization of behavior.</description><identifier>ISSN: 0166-4328</identifier><identifier>EISSN: 1872-7549</identifier><identifier>DOI: 10.1016/S0166-4328(05)80309-2</identifier><identifier>PMID: 1282817</identifier><identifier>CODEN: BBREDI</identifier><language>eng</language><publisher>Shannon: Elsevier Science</publisher><subject>Animals ; Behavior, Animal - drug effects ; Behavioral psychophysiology ; Biological and medical sciences ; Fenclonine - pharmacology ; Fundamental and applied biological sciences. Psychology ; Hydroxyindoleacetic Acid - metabolism ; Male ; N-Methylscopolamine ; Neurotransmission and behavior ; Parasympatholytics - pharmacology ; Psychology. Psychoanalysis. Psychiatry ; Psychology. Psychophysiology ; Psychomotor Performance - drug effects ; Rats ; Rats, Wistar ; Reaction Time - drug effects ; Scopolamine Derivatives - pharmacology ; Serotonin - biosynthesis ; Serotonin Antagonists - pharmacology</subject><ispartof>Behavioural brain research, 1992-10, Vol.51 (1), p.29-40</ispartof><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c250t-4ce8439b9962e1f6b80d40bedcdfadca664122a82f393120f96899d885f006263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=4417789$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1282817$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>JÄKÄLÄ, P</creatorcontrib><creatorcontrib>SIRVIÖ, J</creatorcontrib><creatorcontrib>JOLKKONEN, J</creatorcontrib><creatorcontrib>RIEKKINEN, P. JR</creatorcontrib><creatorcontrib>ACSADY, L</creatorcontrib><creatorcontrib>RIEKKINEN, P</creatorcontrib><title>The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task</title><title>Behavioural brain research</title><addtitle>Behav Brain Res</addtitle><description>The effects of serotonergic dysfunction induced by treatment with p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis, and cholinergic dysfunction induced by scopolamine on the performance of adult rats in the 5-choice serial reaction time task measuring selective attention were studied. Food-deprived rats were trained to detect and respond to brief flashes of light presented randomly in one of five locations, until they reached a stable level of performance (about 4 months). Scopolamine 0.2 mg/kg produced a marked variation in the performance but did not, however, induce any consistent impairment in the discriminative accuracy. Other doses of scopolamine (0.05 and 0.1 mg/kg) or N-methyl-scopolamine 0.2 mg/kg, a peripheral muscarinic receptor antagonist, did not affect discriminative accuracy. Furthermore, scopolamine as well as N-methyl-scopolamine produced a number of other performance deficits, such as significantly decreased overall probability of responding and significantly increased response latencies. PCPA treatment induced an almost total depletion (&gt; 99%) of frontal cortical serotonin and its major metabolite 5-HIAA and reduced the frontal cortical concentrations of noradrenaline (-30%) and dopamine (-42%). During baseline testing conditions, there was a trend for the discriminative accuracy to be decreased by PCPA, although this effect failed to reach significance (P = 0.07). Presenting the stimuli at unpredictable intervals or reducing the intensity of the visual stimulus impaired discriminative accuracy in both PCPA-treated and control rats. The decrease in discriminative accuracy induced by PCPA reached statistical significance when the stimuli were presented faster than normally or the intensity of the visual stimulus was reduced. PCPA treatment did not make the rats more susceptible to the effects of scopolamine on discriminative accuracy. However, PCPA treatment also induced a number of other performance deficits, resulting in a decreased overall tendency to respond. In summary, there is a statistically non-significant trend for the discriminative accuracy to be decreased by PCPA treatment under normal testing conditions, and as the discrimination task is made more difficult (stimulus intensity reduction, presentation of the stimuli at faster than normal rates), the deficit in discriminative accuracy produced by PCPA treatment is revealed. The results suggest a role for brain serotonin in the general organization of behavior.</description><subject>Animals</subject><subject>Behavior, Animal - drug effects</subject><subject>Behavioral psychophysiology</subject><subject>Biological and medical sciences</subject><subject>Fenclonine - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Hydroxyindoleacetic Acid - metabolism</subject><subject>Male</subject><subject>N-Methylscopolamine</subject><subject>Neurotransmission and behavior</subject><subject>Parasympatholytics - pharmacology</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychology. Psychophysiology</subject><subject>Psychomotor Performance - drug effects</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reaction Time - drug effects</subject><subject>Scopolamine Derivatives - pharmacology</subject><subject>Serotonin - biosynthesis</subject><subject>Serotonin Antagonists - pharmacology</subject><issn>0166-4328</issn><issn>1872-7549</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1q3DAUhUVoSSdpHiGgRSnNwo3-LEvLEvoHgS6argdZusJqbMmV5MW8UJ4zmnbItpsruOe758ARQteUfKSEytufbchOcKY-kP5GEU50x87QjqqBdUMv9Cu0e0HeoItSfhNCBOnpOTqnTDFFhx16epgAg_dga8HJ47Wz05xyWieIh9nMJoYIXYhus-BwgZxqaitcDrFOUELBIU5hDDWkiE10eNmKNTnEYPE4J_toHOAmNRivkH3Ki4kWjlHZ1OM1NrhvoSm0bfMPZsYZjP1rWMMCuJry-Ba99mYucHV6L9GvL58f7r519z--fr_7dN9Z1pPaCQtKcD1qLRlQL0dFnCAjOOu8cdZIKShjRjHPNaeMeC2V1k6p3hMimeSX6P0_3zWnPxuUul9CsTC3HiBtZT9wIegg1H9BKrlqWUfw-gRu4wJuv-awmHzYn36g6e9OumnFzT63ekJ5wY5xg9L8GcSlmME</recordid><startdate>19921031</startdate><enddate>19921031</enddate><creator>JÄKÄLÄ, P</creator><creator>SIRVIÖ, J</creator><creator>JOLKKONEN, J</creator><creator>RIEKKINEN, P. JR</creator><creator>ACSADY, L</creator><creator>RIEKKINEN, P</creator><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7QG</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>19921031</creationdate><title>The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task</title><author>JÄKÄLÄ, P ; SIRVIÖ, J ; JOLKKONEN, J ; RIEKKINEN, P. JR ; ACSADY, L ; RIEKKINEN, P</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c250t-4ce8439b9962e1f6b80d40bedcdfadca664122a82f393120f96899d885f006263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Animals</topic><topic>Behavior, Animal - drug effects</topic><topic>Behavioral psychophysiology</topic><topic>Biological and medical sciences</topic><topic>Fenclonine - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Hydroxyindoleacetic Acid - metabolism</topic><topic>Male</topic><topic>N-Methylscopolamine</topic><topic>Neurotransmission and behavior</topic><topic>Parasympatholytics - pharmacology</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychology. Psychophysiology</topic><topic>Psychomotor Performance - drug effects</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reaction Time - drug effects</topic><topic>Scopolamine Derivatives - pharmacology</topic><topic>Serotonin - biosynthesis</topic><topic>Serotonin Antagonists - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>JÄKÄLÄ, P</creatorcontrib><creatorcontrib>SIRVIÖ, J</creatorcontrib><creatorcontrib>JOLKKONEN, J</creatorcontrib><creatorcontrib>RIEKKINEN, P. JR</creatorcontrib><creatorcontrib>ACSADY, L</creatorcontrib><creatorcontrib>RIEKKINEN, P</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>Animal Behavior Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Behavioural brain research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>JÄKÄLÄ, P</au><au>SIRVIÖ, J</au><au>JOLKKONEN, J</au><au>RIEKKINEN, P. JR</au><au>ACSADY, L</au><au>RIEKKINEN, P</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task</atitle><jtitle>Behavioural brain research</jtitle><addtitle>Behav Brain Res</addtitle><date>1992-10-31</date><risdate>1992</risdate><volume>51</volume><issue>1</issue><spage>29</spage><epage>40</epage><pages>29-40</pages><issn>0166-4328</issn><eissn>1872-7549</eissn><coden>BBREDI</coden><abstract>The effects of serotonergic dysfunction induced by treatment with p-chlorophenylalanine (PCPA), an inhibitor of serotonin synthesis, and cholinergic dysfunction induced by scopolamine on the performance of adult rats in the 5-choice serial reaction time task measuring selective attention were studied. Food-deprived rats were trained to detect and respond to brief flashes of light presented randomly in one of five locations, until they reached a stable level of performance (about 4 months). Scopolamine 0.2 mg/kg produced a marked variation in the performance but did not, however, induce any consistent impairment in the discriminative accuracy. Other doses of scopolamine (0.05 and 0.1 mg/kg) or N-methyl-scopolamine 0.2 mg/kg, a peripheral muscarinic receptor antagonist, did not affect discriminative accuracy. Furthermore, scopolamine as well as N-methyl-scopolamine produced a number of other performance deficits, such as significantly decreased overall probability of responding and significantly increased response latencies. PCPA treatment induced an almost total depletion (&gt; 99%) of frontal cortical serotonin and its major metabolite 5-HIAA and reduced the frontal cortical concentrations of noradrenaline (-30%) and dopamine (-42%). During baseline testing conditions, there was a trend for the discriminative accuracy to be decreased by PCPA, although this effect failed to reach significance (P = 0.07). Presenting the stimuli at unpredictable intervals or reducing the intensity of the visual stimulus impaired discriminative accuracy in both PCPA-treated and control rats. The decrease in discriminative accuracy induced by PCPA reached statistical significance when the stimuli were presented faster than normally or the intensity of the visual stimulus was reduced. PCPA treatment did not make the rats more susceptible to the effects of scopolamine on discriminative accuracy. However, PCPA treatment also induced a number of other performance deficits, resulting in a decreased overall tendency to respond. In summary, there is a statistically non-significant trend for the discriminative accuracy to be decreased by PCPA treatment under normal testing conditions, and as the discrimination task is made more difficult (stimulus intensity reduction, presentation of the stimuli at faster than normal rates), the deficit in discriminative accuracy produced by PCPA treatment is revealed. The results suggest a role for brain serotonin in the general organization of behavior.</abstract><cop>Shannon</cop><pub>Elsevier Science</pub><pmid>1282817</pmid><doi>10.1016/S0166-4328(05)80309-2</doi><tpages>12</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0166-4328
ispartof Behavioural brain research, 1992-10, Vol.51 (1), p.29-40
issn 0166-4328
1872-7549
language eng
recordid cdi_proquest_miscellaneous_73441748
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Animals
Behavior, Animal - drug effects
Behavioral psychophysiology
Biological and medical sciences
Fenclonine - pharmacology
Fundamental and applied biological sciences. Psychology
Hydroxyindoleacetic Acid - metabolism
Male
N-Methylscopolamine
Neurotransmission and behavior
Parasympatholytics - pharmacology
Psychology. Psychoanalysis. Psychiatry
Psychology. Psychophysiology
Psychomotor Performance - drug effects
Rats
Rats, Wistar
Reaction Time - drug effects
Scopolamine Derivatives - pharmacology
Serotonin - biosynthesis
Serotonin Antagonists - pharmacology
title The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A24%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20effects%20of%20p-chlorophenylalanine-induced%20serotonin%20synthesis%20inhibition%20and%20muscarinic%20blockade%20on%20the%20performance%20of%20rats%20in%20a%205-choice%20serial%20reaction%20time%20task&rft.jtitle=Behavioural%20brain%20research&rft.au=J%C3%84K%C3%84L%C3%84,%20P&rft.date=1992-10-31&rft.volume=51&rft.issue=1&rft.spage=29&rft.epage=40&rft.pages=29-40&rft.issn=0166-4328&rft.eissn=1872-7549&rft.coden=BBREDI&rft_id=info:doi/10.1016/S0166-4328(05)80309-2&rft_dat=%3Cproquest_pubme%3E73441748%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16384128&rft_id=info:pmid/1282817&rfr_iscdi=true